BioNJ Scientist Story Telling Series:
Guest Blog » Hear from an Expert About Why Medical Innovation is Critical to Drive Change for Patients with Rare Diseases – An Interview with Ellen Welch, Ph.D., Chief Scientific Officer, PTC
Guest Blog » BioNJ Scientist Storytelling Series – An Interview with Timothy Watson, Ph.D., Executive Director and Global Leader of the Chemistry, Manufacturing, and Controls (CMC) Advisory Office, Pfizer
BioNJ Thought Leadership Guest Blogs:
Pharmacy Benefit Manager Practices: Creating Barriers to Treatment for Patients Living With Autoimmune Diseases – Blog written by Molly Murray, President & CEO, Autoimmune Association
Guest Blog » Innovation in Cancer Therapies: Protecting Patient Access and Future Cures – Blog written by Patricia Goldsmith, CEO, CancerCare
Guest Blog » CMS Coverage Determination for Alzheimer’s Treatments Is a Lesson On Patient Access – Blog written by Sue Peschin, President & CEO, Alliance for Aging Research
Guest Blog » When ICER’s Health Economists Hijack the Patient-Physician Relationship – Blog written by Josie Cooper, Executive Director, Alliance for Patient Access